SCHEMBL30262010

SCHEMBL30262010

CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 3/20 0.64
▸ CTSS P25774 3/20 0.64
▸ CTSK P43235 3/20 0.64
▸ CTSH P09668 1/20 0.64
▸ C5AR1 P21730 2/20 0.62
▸ APLNR P35414 2/20 0.61
▸ KEAP1 Q14145 1/20 0.60
▸ GLP1R P43220 9/20 0.58
▸ GCGR P47871 8/20 0.58
▸ GIPR P48546 5/20 0.57
▸ NPY1R P25929 1/20 0.56
▸ NPY2R P49146 1/20 0.56
▸ NPY4R P50391 1/20 0.56
▸ NPY5R Q15761 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30894433 0.93 APLNR (0.60) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL30717268 0.92 C5AR1 (0.65) C5AR1APLNRKEAP1GLP1RGCGR
SCHEMBL31182480 0.91 C5AR1 (0.64) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL30631666 0.91 CTSL (0.62) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL30432727 0.90 APLNR (0.63) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL31544061 0.90 C5AR1 (0.73) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL31182802 0.89 KEAP1 (0.66) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL30436302 0.88 GLP1R (0.67) C5AR1KEAP1GLP1RGCGRNPY1R
SCHEMBL30487564 0.88 C5AR1 (0.71) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL29737187 0.87 C5AR1 (0.75) C5AR1KEAP1GLP1RGCGRNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback